Syneos HealthCLOSE X
CEO: Alistair Macdonald
Year of Investment: 2010
Syneos Health (NASDAQ: SYNH) is the only fully integrated biopharmaceutical solutions organization. The company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies - INC Research and inVentiv Health - Syneos Health brings together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries.
THL acquired inVentiv Health in August 2010. The company merged with INC Research on May 10, 2017.